Pinatuzumab vedotin

Monoclonal antibody
  • none
IdentifiersCAS Number
  • 1313706-14-7
ChemSpider
  • none
UNII
  • 6KA1906BLC
Chemical and physical dataFormulaC6748H10377N1773O2083S44Molar mass151081.21 g·mol−1

Pinatuzumab vedotin (INN;[1] development codes DCDT2980S and FCU2703) is a monoclonal antibody designed for the treatment of B-cell malignancies.[2]

This drug was developed by Genentech/Roche.[citation needed]

References

  1. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 108" (PDF). WHO Drug Information. 26 (4).
  2. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Pinatuzumab Vedotin, American Medical Association.
  • v
  • t
  • e
  • v
  • t
  • e
Monoclonal antibodies for tumors
Tumor
Human
Mouse
Chimeric
Humanized
Rat/mouse hybrid
Chimeric + humanized